SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma

[1]  Shile Huang,et al.  Knocking out alpha-synuclein in melanoma cells dysregulates cellular iron metabolism and suppresses tumor growth , 2021, Scientific Reports.

[2]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[3]  M. Versino,et al.  Genetic parkinsonisms and cancer: a systematic review and meta-analysis , 2020, Reviews in the neurosciences.

[4]  M. Ejma,et al.  The Links between Parkinson’s Disease and Cancer , 2020, Biomedicines.

[5]  Yan-yan Li,et al.  Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma , 2020, BioMed research international.

[6]  G. Akpinar,et al.  Investigation of the Involvement of Parkin in Parkinson's Disease and Cancer by Monitoring the Changes in SH-SY5Y Cells at the Nuclear Proteome Level , 2020, AntiCancer Research.

[7]  S. Belinsky,et al.  Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients. , 2020, Lung cancer.

[8]  Xiaole Shirley Liu,et al.  TIMER2.0 for analysis of tumor-infiltrating immune cells , 2020, Nucleic Acids Res..

[9]  Xiqun Chen,et al.  Association Between Parkinson’s Disease and Melanoma: Putting the Pieces Together , 2020, Frontiers in Aging Neuroscience.

[10]  N. Al-Moghrabi,et al.  Curcumin induces re-expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines , 2020, Oncology reports.

[11]  Ying Xu,et al.  ERK/MAPK signalling pathway and tumorigenesis , 2020, Experimental and therapeutic medicine.

[12]  T. Lancet.  Lung cancer: some progress, but still a lot more to do , 2019, The Lancet.

[13]  Pengcheng Zhang,et al.  Association between Parkinson's Disease and Risk of Cancer: A PRISMA-compliant Meta-analysis. , 2019, ACS chemical neuroscience.

[14]  I. Melero,et al.  Dendritic cells in cancer immunology and immunotherapy , 2019, Nature Reviews Immunology.

[15]  D. Missiakas,et al.  FPR1 is the plague receptor on host immune cells , 2019, Nature.

[16]  Tingfu Du,et al.  Injection of α-syn-98 Aggregates Into the Brain Triggers α-Synuclein Pathology and an Inflammatory Response , 2019, Front. Mol. Neurosci..

[17]  Xiaoyan Xu,et al.  CD48 is a key molecule of immunomodulation affecting prognosis in glioma , 2019, OncoTargets and therapy.

[18]  J. Power,et al.  Alzheimer’s Disease and Cancer: When Two Monsters Cannot Be Together , 2019, Front. Neurosci..

[19]  K. Ji,et al.  Ras and Rap1: A tale of two GTPases. , 2019, Seminars in cancer biology.

[20]  T. Südhof,et al.  Cell Biology and Pathophysiology of α-Synuclein. , 2018, Cold Spring Harbor perspectives in medicine.

[21]  Matthew Collin,et al.  Human dendritic cell subsets: an update , 2018, Immunology.

[22]  X. Qi,et al.  SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis , 2018, Cancer science.

[23]  B. Zhivotovsky,et al.  Cell death-based treatment of lung adenocarcinoma , 2018, Cell Death & Disease.

[24]  Zhi Li,et al.  SNCA Is a Functionally Low-Expressed Gene in Lung Adenocarcinoma , 2018, Genes.

[25]  Chad J. Creighton,et al.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.

[26]  E. Hirsch,et al.  PI3K Signaling in Tissue Hyper-Proliferation: From Overgrowth Syndromes to Kidney Cysts , 2017, Cancers.

[27]  Bin Zhang,et al.  DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database , 2016, Nucleic Acids Res..

[28]  Yang Liu,et al.  Risk of lung cancer in Parkinson's disease , 2016, Oncotarget.

[29]  A. Lánczky,et al.  miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients , 2016, Breast Cancer Research and Treatment.

[30]  E. Friedman,et al.  Cutaneous malignant melanoma and Parkinson disease: Common pathways? , 2016, Annals of neurology.

[31]  K. E. Visser,et al.  Neutrophils in cancer: neutral no more , 2016, Nature Reviews Cancer.

[32]  S. Lam,et al.  Macrophages, Inflammation, and Lung Cancer. , 2016, American journal of respiratory and critical care medicine.

[33]  J. Austin,et al.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[34]  M. Peinado,et al.  Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer , 2015, Epigenetics & Chromatin.

[35]  Wei Zhang,et al.  Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer. , 2015, International journal of clinical and experimental pathology.

[36]  R. Lothe,et al.  Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma , 2015, Hepatology.

[37]  Qi Guo,et al.  Detection of SNCA and FBN1 Methylation in the Stool as a Biomarker for Colorectal Cancer , 2015, Disease markers.

[38]  Liquid Biopsies.  Non-small-cell lung cancer , 2015, Nature Reviews Disease Primers.

[39]  Will Liao,et al.  The cellular and molecular origin of tumor-associated macrophages , 2014, Science.

[40]  Alfonso Valencia,et al.  Molecular Evidence for the Inverse Comorbidity between Central Nervous System Disorders and Cancers Detected by Transcriptomic Meta-analyses , 2014, PLoS genetics.

[41]  J. Delabie,et al.  Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma , 2013, Epigenetics.

[42]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[43]  J. Jankovic,et al.  The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells , 2012, PloS one.

[44]  R. Liu,et al.  Meta-analysis of the relationship between Parkinson disease and melanoma , 2011, Neurology.

[45]  Tianhong Pan,et al.  The association between Parkinson's disease and melanoma , 2011, International journal of cancer.

[46]  F. Levi-Schaffer,et al.  CD48: A co-stimulatory receptor of immunity. , 2011, The international journal of biochemistry & cell biology.

[47]  E. Plaisance,et al.  Imaging systems for westerns: chemiluminescence vs. infrared detection. , 2009, Methods in molecular biology.

[48]  Robert Tibshirani,et al.  An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML. , 2008, Blood.

[49]  David Bryant,et al.  DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists , 2007, Nucleic Acids Res..

[50]  J. Bergh,et al.  Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  T. Barrette,et al.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.

[52]  J. Baselga,et al.  Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[53]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[54]  Jing-Yuan Fang,et al.  The MAPK signalling pathways and colorectal cancer. , 2005, The Lancet. Oncology.

[55]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[56]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..